News
Alumni news: TargED Biopharmaceuticals Secures Prestigious EIC Grant to Advance Targeted Thrombolytic Therapy
TargED Biopharmaceuticals, Venture Challenge 2018 alumnus and Utrecht-based biotech company, has secured a significant blended finance award from the European Innovat
Alumni News: ShanX Medtech & ARTIC Win Gerard & Anton Award 2025
Two LifeSciences@Work alumni have been named among the 10 most promising startups in Brainport Eindhoven by winning the prestigious Gerard & Anton Award 2025.
NeuroNova Tx wins Venture Challenge Spring 2025!
The winner of the Venture Challenge was announced today at the Dutch Biotech Event. The proud winner of the 2025 Spring edition is NeuroNova Tx! Their groundbreaking stem cell research stimulates brain repair in newborn babies who suffered from brain injury.
STENTiT reaches clinical milestone with first-in-human trial
We’re proud to celebrate a major milestone from our Venture Challenge Fall 2016 alumnus STENTiT: the company’s regenerative stent has officially entered its first-in-human clinical trial.Alumni news: Lumox wins Innovator Award at Philips Innovation Award 2025
We are proud to share that Venture Challenge 2023 alumnus Lumox has won the Innovator Award at the 20th edition of the Philips Innovation Award — the largest student-led entrepr
Alumni Spotlight: Capsule Photonics Wins Health Innovation Award at Amsterdam Science & Innovation Awards 2025
Capsule Photonics, winner of the Venture Challenge Winter 2024/2025, has received the Health Innovation Award at the Amsterdam Scie
Alumni Update: Scope Biosciences Raises €6M to Scale Up CRISPR Diagnostics Platform
Venture Challenge 2020 alumnus Scope Biosciences has announced a new follow-on investment from SHIFT Invest and Oost NL, marking the next growth phase for its CRISPR-based diagnostics platform, scopeDx®.
Santiago WISE Award 2025: €20,000 in Grants for Women Entrepreneurs in MedTech
Are you a female entrepreneur in MedTech looking to strengthen your innovation potential and boost your chances of success and funding?
Alumni news: ARTIC Technologies Secures €350,000 Investment from Brabant Startup Fonds!
Proefdiervrij Venture Challenge 2023 alumnus ARTIC Technologies has secured €350,000 in funding from Brabant Startup Fonds BV (BSF) to accelerate the development of its next-generation in-vitro cell culture platform.